Global Connected Drug Delivery Devices Industry

Global Connected Drug Delivery Devices Industry

  • April 2021 •
  • 170 pages •
  • Report ID: 6031194 •
  • Format: PDF
Abstract:
- Global Connected Drug Delivery Devices Market to Reach $1.5 Billion by 2027
- Amid the COVID-19 crisis, the global market for Connected Drug Delivery Devices estimated at US$166.9 Million in the year 2020, is projected to reach a revised size of US$1.5 Billion by 2027, growing at aCAGR of 36.4% over the period 2020-2027. Connected Drug Delivery Devices, one of the segments analyzed in the report, is projected to record 35.5% CAGR and reach US$996 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Integrated Connected Devices segment is readjusted to a revised 38.4% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $50.4 Million, While China is Forecast to Grow at 34.4% CAGR
- The Connected Drug Delivery Devices market in the U.S. is estimated at US$50.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$236.2 Million by the year 2027 trailing a CAGR of 34.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 32.9% and 30.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 24.8% CAGR.

- Select Competitors (Total 42 Featured) -
  • Adherium Limited
  • Aterica
  • Biocorp
  • FindAir
  • Merck KGaA
  • Phillips Medisize
  • Propeller Health
  • Proteus Digital Health
  • West Pharmaceutical Services, Inc.